These findings suggest a germline-somatic interaction mechanism whereby germline variation may mediate cancer risk through its effect on the burden of a somatic driver: the TMPRSS2:ERG fusion oncogene (Supplementary Fig. 5). Here, TMPRSS2 is linked to cancer.